A detailed history of Bare Financial Services, Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Bare Financial Services, Inc holds 41 shares of LGND stock, worth $8,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Previous 10 310.0%
Holding current value
$8,235
Previous $1.14 Million 538.79%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$112.56 - $177.14 $3,489 - $5,491
31 Added 310.0%
41 $7.26 Million
Q2 2025

Aug 13, 2025

BUY
$96.67 - $118.22 $290 - $354
3 Added 42.86%
10 $1.14 Million
Q1 2025

May 12, 2025

BUY
$105.14 - $122.23 $735 - $855
7 New
7 $736,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.39B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.